BioLineRx Ltd. (BLRX)
2.88
+0.01
(+0.35%)
USD |
NASDAQ |
Jan 15, 16:00
2.90
+0.02
(+0.69%)
After-Hours: 20:00
BioLineRx EPS Diluted (Quarterly): -0.223 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Compugen Ltd. | -0.0746 |
| Can-Fite BioPharma Ltd. | -- |
| BiomX, Inc. | -5.546 |
| Nasus Pharma Ltd. | -- |
| Regentis Biomaterials Ltd. | -- |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -0.9816M |
| Revenue (Quarterly) | 0.429M |
| Total Expenses (Quarterly) | 1.411M |
| Enterprise Value | -1.302M |
| Gross Profit Margin (Quarterly) | 52.45% |
| Profit Margin (Quarterly) | -228.8% |
| Earnings Yield | -47.42% |
| Normalized Earnings Yield | -35.91 |